Candriam S.C.A. Acquires 19,155 Shares of Cardinal Health, Inc. $CAH

Candriam S.C.A. grew its holdings in shares of Cardinal Health, Inc. (NYSE:CAHFree Report) by 10.8% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 196,163 shares of the company’s stock after acquiring an additional 19,155 shares during the period. Candriam S.C.A. owned about 0.08% of Cardinal Health worth $30,790,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of CAH. Latitude Advisors LLC raised its position in Cardinal Health by 2.1% during the 3rd quarter. Latitude Advisors LLC now owns 2,598 shares of the company’s stock worth $408,000 after purchasing an additional 53 shares during the last quarter. WESPAC Advisors LLC grew its position in shares of Cardinal Health by 1.0% in the 3rd quarter. WESPAC Advisors LLC now owns 6,644 shares of the company’s stock valued at $1,043,000 after buying an additional 63 shares during the last quarter. Kathmere Capital Management LLC increased its stake in shares of Cardinal Health by 1.6% in the third quarter. Kathmere Capital Management LLC now owns 4,091 shares of the company’s stock valued at $642,000 after buying an additional 65 shares during the period. Vermillion & White Wealth Management Group LLC raised its position in shares of Cardinal Health by 55.0% during the second quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock worth $34,000 after acquiring an additional 71 shares during the last quarter. Finally, Woodward Diversified Capital LLC lifted its stake in shares of Cardinal Health by 4.0% in the third quarter. Woodward Diversified Capital LLC now owns 1,854 shares of the company’s stock worth $291,000 after acquiring an additional 72 shares during the period. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Price Performance

Shares of Cardinal Health stock opened at $225.88 on Tuesday. The business has a 50-day simple moving average of $207.28 and a 200 day simple moving average of $180.77. Cardinal Health, Inc. has a one year low of $120.72 and a one year high of $230.81. The firm has a market capitalization of $53.15 billion, a price-to-earnings ratio of 32.50, a PEG ratio of 1.48 and a beta of 0.64.

Cardinal Health (NYSE:CAHGet Free Report) last announced its quarterly earnings results on Thursday, February 5th. The company reported $2.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.31 by $0.32. The business had revenue of $65.63 billion for the quarter, compared to analyst estimates of $64.88 billion. Cardinal Health had a negative return on equity of 92.50% and a net margin of 0.68%.The company’s quarterly revenue was up 18.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.93 earnings per share. On average, sell-side analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Analyst Ratings Changes

A number of analysts have weighed in on the stock. Deutsche Bank Aktiengesellschaft increased their target price on shares of Cardinal Health from $195.00 to $208.00 and gave the company a “hold” rating in a research report on Tuesday, November 18th. Wall Street Zen raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, November 8th. Leerink Partners boosted their target price on shares of Cardinal Health from $240.00 to $268.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Wells Fargo & Company upped their price target on shares of Cardinal Health from $221.00 to $237.00 and gave the company an “overweight” rating in a research report on Thursday, January 15th. Finally, Morgan Stanley set a $255.00 price objective on Cardinal Health in a research report on Friday. Fifteen investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $241.27.

Read Our Latest Research Report on Cardinal Health

Cardinal Health Profile

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

See Also

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.